Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Urologic Clinics of North America|July 7, 2019
Management of Clinical Stage I Germ Cell TumorsBruce J Roth
The Urologic Clinics of North America|April 25, 2006
Changing perspectives of the role of chemotherapy in advanced prostate cancerEarle F Burgess, Bruce J Roth
The Oncologist|January 18, 2007
Management of recurrent testicular germ cell tumorsGuru Sonpavde, Thomas E Hutson, Bruce J Roth
Investigational New Drugs|November 27, 2002
Piritrexim in advanced, refractory carcinoma of the urothelium (E3896): a phase II trial of the Eastern Cooperative Oncology GroupBruce J Roth, Judith Manola, Robert Dreicer, et al.
Cancer|May 7, 2008
Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802): a trial of the Eastern Cooperative Oncology GroupRobert Dreicer, Hailun Li, Matthew M Cooney, et al.
The Journal of Urology|October 27, 2015
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015William T Lowrance, Bruce J Roth, Erin Kirkby, et al.
Urology|August 16, 2005
Performance-enhancing supplement use in patients with testicular cancerSam S Chang, Bert Ivey, Joseph A Smith, et al.
Cancer|June 28, 2007
Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology GroupRobert Dreicer, Shuli Li, Judith Manola, et al.
Cancer|June 19, 2009
Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology GroupRobert Dreicer, Hailun Li, Mark Stein, et al.
The Journal of Urology|June 7, 2002
Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissectionSam S Chang, Joseph A Smith, Christopher Girasole, et al.
Pageof 4